Keros Therapeutics, Inc. (KROS)
20.26
+0.13
(+0.65%)
USD |
NASDAQ |
Dec 19, 16:00
20.21
-0.05
(-0.25%)
After-Hours: 20:00
Keros Therapeutics Total Assets (Quarterly): 742.78M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Eli Lilly & Co. | 114.94B |
| Pfizer Inc. | 208.73B |
| Innoviva, Inc. | 1.429B |
| Ocugen, Inc. | 57.60M |
| Bionano Genomics, Inc. | 79.06M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 39.20M |
| Shareholders Equity (Quarterly) | 703.58M |
| Debt to Equity Ratio | 0.0248 |
| Current Ratio | 29.86 |
| Net Debt Paydown Yield | -0.11% |